Summary
To elucidate the role of hypertension as part of the insulin resistance syndrome, the longitudinal relationships of hypertension and overweight with hyperinsulinaemia and glucose tolerance were examined in the Dutch and Finnish cohorts of the Seven Countries Study (Zutphen, and east and west Finland). Three cohorts of men, born between 1900 and 1919, were first examined in 1959/1960. At the 30-year follow-up survey a 2-h glucose tolerance test was carried out on 619 of the surviving men, and fasting insulin was also measured. Blood pressure and body mass index (BMI) were measured several times during the entire 30-year follow-up period. In crosssectional analyses, men with diabetes and impaired glucose tolerance at the 30-year follow-up examination had a significantly higher systolic blood pressure and a higher prevalence of hypertension than men with normal glucose tolerance, independent of age, cohort and BMI (p < 0.01). These differences had already been seen 5, 20 and 30 years earlier. Subjects with hyperinsulinaemia (fasting insulin > 9.2 mU/1) had a higher BMI and a higher prevalence of hypertension. This cross-sectional association with hypertension was independent of age, cohort and BMI. BMI levels of men with hyperinsulinaemia had been shown to be higher 5, 20 and 30 years earlier, but blood pressure levels had not. These results indicate that hypertension is independently associated with glucose tolerance and insulin resistance in three Caucasian cohorts. Changes in blood pressure precede abnormal glucose tolerance but not hyperinsulinaemia; therefore, glucose tolerance appears to be a stronger correlate of hypertension than hyperinsulinaemia.
Article PDF
Similar content being viewed by others
Abbreviations
- GTT:
-
Glucose tolerance test
- BMI:
-
body mass index
- NIDDM:
-
non-insulin-dependent diabetes mellitus
References
Reaven GM (1988) Banting lecture 1988: role of insulin resistance in human disease. 37: 335–344
Björntorp P (1988) The associations between obesity, adipose tissue distribution and disease. Acta Med Scand [Suppl 723]: 121–134
Kaplan NM (1989) The deadly quartet: upper-body adiposity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 149: 1514–1520
DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194
Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP (1992) Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41: 715–722
Donahue RP, Skyler JS, Schneiderman B, Prineas RJ (1990) Hyperinsulinemia and elevated blood pressure: cause, confounder, or coincidence? Am J Epidemiol 132: 827–836
Modan M, Halkin H, Almog S et al. (1985) Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 807–817
Ferrannini E, Buzzigioli G, Bonadonna R et al. (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350–357
Zavaroni I, Bonora E, Pagliara M et al. (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702–706
Laakso M, Sarlund H, Mykkänen L (1989) Essential hypertension and insulin resistance in non-insulin-dependent diabetes. Eur J Clin Invest 19: 518–526
Collins VR, Dowse GK, Finch CF, Zimmet PZ (1990) An inconsistent relationship between insulin and blood pressure in three Pacific Island populations. J Clin Epidemiol 43: 1369–1378
Asch S, Wingard DL, Barrett-Connor EL (1991) Are insulin and hypertension independently related? Ann Epidemiol 1: 231–244
Muller DC, Elahi D, Pratley RE, Tobin JD, Andres R (1993) An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab 76: 544–548
Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffner SM (1993) Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. Diabetes 42: 154–161
Keys A (1970) Coronary heart disease in seven countries. Circulation 41 [Suppl 1]: 1–211
Keys A, Aravanis C, Blackburn HW et al. (1967) Epidemiological studies related to coronary heart disease: characteristics of men aged 40–59 in seven countries. Acta Med Scand 460 [Suppl 1]: 1–392
World Health Organization (1985) Diabetes Mellitus. Report of a WHO Study Group. WHO Technical Report Series no. 727. Geneva
World Health Organization (1978) Arterial hypertension. Technical Report Series no. 628. Geneva
Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW (1981) Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 19: 838–839
Sullivan DR, Kruijswijk Z, West CE, Kohlmeier M, Katan MB (1985) Determination of serum triglycérides by an enzymatic method not affected by free glycerol. Clin Chem 31: 1227–1228
Warnick GR, Benderson J, Albers JJ (1982) Dextran sulfate-Mg2+ precipitation procedure for quantification of high-density-lipoprotein cholesterol. Clin Chem 28: 1379–1388
Rose GA, Blackburn H (1968) Cardiovascular survey methods. Geneva, World Health Organization
SAS Institute (1985) SAS user’s guide: statistics. SAS Institute Inc., Cary
Saad MF, Lillioja S, Swinburn B et al. (1991) Racial differences between blood pressure and insulin resistance. N Engl J Med 324: 733–739
Falkner B, Hulman D, Tannebaum J, Kushner H (1990) Insulin resistance and blood pressure in young black men. Hypertension 16: 706–711
Lithell HOL (1991) Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diabetes Care 14: 203–209
Jarrett JR (1992) In defence of insulin: a critique of syndrome X. Lancet 340: 469–471
Weinberg CR (1993) Toward a clearer definition of confounding. Am J Epidemiol 137: 1–8
Alderman MH (1994) Non-pharmacological treatment of hypertension. Lancet 344: 307–311
Christlieb AR, Krolewski AS, Warram JH, Soeldner JS (1985) Is there a link between hypertension and obesity? Hypertension 7 [Suppl 2]: 54–57
Wing RR, Bunker CH, Kuller LH, Matthews KA (1989) Insulin, body mass index, and cardiovascular risk factors in premenopausal women. Arteriosclerosis 9: 479–484
Mbanya JN, Thomas TH, Wilkinson R, Alberti KGMM, Taylor R (1988) Hypertension and hyperinsulinaemia: a relation in diabetes but not essential hypertension. Lancet I: 733–734
Amery A, Brixko R, Clement D et al. (1986) Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet II: 589–592
Cambien F, Warnet JM, Eschwege E, Jacqueson A, Richard JL, Rosselin G (1987) Body mass, blood pressure, glucose and lipids - does plasma insulin explain their relationships? Arteriosclerosis 7: 197–202
Pan WH, Cedres LB, Liu K et al. (1986) Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123: 504–516
Feskens EJM, Kromhout D (1992) Glucose tolerance and the risk of cardiovascular diseases: the Zutphen Study. J Clin Epidemiol 45: 1327–1334
Feldman RD, Bierbier GS (1993) Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet 342: 707–709
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feskens, E.J.M., Tuomilehto, J., Stengård, J.H. et al. Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the finnish and dutch cohorts of the seven countries study. Diabetologia 38, 839–847 (1995). https://doi.org/10.1007/s001250050361
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050361